ArticleWorld journal of microbiology & biotechnology2025
Structural and functional characterization of the New Delhi metallo beta-lactamase-1 (NDM-1) D254A mutant: a biochemical, microbiological and bioinformatics study.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New Delhi Metallo-β-lactamase-1 (NDM-1) belongs to the carbapenemase family of enzymes, which can hydrolyse a wide range of β-lactam antibiotics. To date, 91 NDM-1 variants have been reported globally. In this study, we generated a novel mutant, NDM-1 D254A, through site-directed mutagenesis to investigate the functional role of non-active site residue Asp254. The wild-type NDM-1 and D254A mutant were cloned, purified, and systematically analyzed using steady-state kinetic assays and circular dichroism spectroscopy. Subsequently, we conducted Insilico studies, which include molecular docking and molecular dynamics (MD) simulations. The D254A mutant has reduced catalytic activity, thus indicating impaired β-lactam hydrolysis. Structural and computational analysis revealed that Asp254 plays an essential role in maintaining the protein stability. These findings illustrate the importance of Asp254 in maintaining the NDM-1 activity and provide the mechanistic insights into the structure-function relationship. This study enhances our understanding of NDM-1 variants and may aid the rational design of targeted inhibitors to counteract the rising global threat of NDM-1 mediated antibiotic resistance.
Indexed as
Identifiers
41474476What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.